Kerafast产品代理

产品分类 > 科研试剂 > Kerafast产品代理

Kerafast产品代理

Kerafast 是一家位于波士顿的试剂公司,其主要使命是为全球科学界提供易于使用的独特实验室研究工具。我们的产品组合包括细胞系、抗体、小分子、染料等,其中许多在其他地方无法获得。自 2011 年成立以来,来自全球 190 多个机构的研究人员通过我们的在线平台提供了他们的创新试剂,无需通过传统的材料转让协议流程即可快速获取材料。
我们处理提供实验室的所有销售和运输物流,并从每次销售中返还丰厚的特许权使用费。因此,我们帮助提供实验室节省时间和资源,同时为进一步研究提供额外资金。采购科学家可以更轻松地发现和获取其他地方通常无法获得的独特试剂,同时还可以资助其他研究人员的工作。这创建了一个全球科学家社区,他们贡献和获取 Reagent for the Greater Good,以加速他们自己的研究以及整体科学进步。
2018 年,Kerafast 与 Absolute Antibody 合并,Absolute Antibody 是一家总部位于英国的公司,其愿景是为所有研究人员提供重组抗体技术。此次合并将两家公司合并在一起,共同致力于改善科学界可用的研究工具的选择。
价格: 0.00

Kerafast is a Boston-based reagent company whose primary mission is to make unique laboratory-made research tools 

easily accessible   to the global scientific community. Our portfolio includes cell lines,   antibodies, small molecules, dyes and more, many of which are not available   elsewhere. Since our founding in 2011, researchers from more than 190   institutions worldwide have made their innovative reagents available through   our online platform, where the materials can be quickly accessed without   needing to go through the traditional Material Transfer Agreement process.

We handle   all selling and shipping logistics for the providing laboratory, as well as   return generous royalty payments from every sale. We therefore help providing   labs save time and resources, while generating extra funding for further   research. Procuring scientists can more easily discover and access unique reagents   that are often unavailable elsewhere, while also funding the work of other   researchers. This creates a global community of scientists contributing and   accessing Reagents for the Greater Good to accelerate their own research as   well as scientific progress overall.

   

In 2018, Kerafast merged with Absolute Antibody, a UK-based company with a vision to make recombinant antibody technology available to all researchers. The merger brought together two companies with a shared commitment to improving the selection of research tools available to the scientific community.